Management of epistaxis in patients with ventricular assist device: a retrospective review
Abstract Background Patients with a ventricular assist device (VAD) are at risk for epistaxis due to the need for anticoagulation. Additionally, these patients develop acquired von Willebrand syndrome (AvWS) due to these devices. Management is complicated by the risk of thrombosis if anticoagulation...
Main Authors: | Clifford Scott Brown, Ralph Abi-Hachem, David Woojin Jang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Journal of Otolaryngology - Head and Neck Surgery |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40463-018-0295-6 |
Similar Items
-
Relation of blood group with epistaxis
by: Adhikari, Prakash, et al.
Published: (2008-12-01) -
Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
by: Antoine Rauch, et al.
Published: (2019-02-01) -
Hemostatic complications associated with ventricular assist devices
by: Talal Hilal, et al.
Published: (2019-10-01) -
Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus‐formation analysis system
by: Seiji Takashio, et al.
Published: (2020-10-01) -
Endoscopic treatment of severe episodic epistaxis in a patient with a left-ventricular assist device
by: Bharat Akhanda Panuganti, et al.
Published: (2020-09-01)